Safety of oral immunization with recombinant urease in H-pylori-infected humans

被引：0
|
作者：
Kreiss, C
Buclin, T
Cosma, M
Biollaz, J
CorthesyTheulaz, I
Porta, N
Glauser, M
Appenzeller, M
Pappo, J
Nichols, R
Stolte, M
Monath, T
Blum, AL
Michetti, P
机构：
[1] UNIV LAUSANNE HOSP, LAUSANNE, SWITZERLAND
[2] UNIV HOSP BAYREUTH, BAYREUTH, GERMANY
[3] ORAVAX INC, CAMBRIDGE, MA USA
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A162 / A162
页数：1
相关论文
共 50 条
  • [1] Oral immunization of H-pylori infected adults with recombinant urease and LT adjuvant
    Michetti, P
    Kreiss, C
    Kotloff, K
    Porta, N
    Blanco, JL
    Bachmann, D
    Saldinger, PF
    CorthesyTheulaz, I
    Losonsky, G
    Nichols, R
    Stolte, M
    Monath, T
    Ackerman, S
    Blum, AL
    GASTROENTEROLOGY, 1997, 112 (04) : A1042 - A1042
  • [2] Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection
    Kreiss, C
    Buclin, T
    Cosma, M
    CorthesyTheulaz, I
    Michetti, P
    LANCET, 1996, 347 (9015): : 1630 - 1631
  • [3] Will saliva test be a good method to detect Helicobacter pylori in H-pylori-infected patients?
    Young, Shih-Hao
    Luo, Jiing-Chyuan
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2016, 79 (07) : 351 - 352
  • [4] Atrophy and extent of intestinal metaplasia in a cohort of H-pylori-infected patients
    Guarner, J
    Herrera, R
    Mohar, A
    Sanchez, L
    Halperin, D
    Ley, C
    Parsonnet, J
    GASTROENTEROLOGY, 1999, 116 (04) : A416 - A416
  • [5] Chemoprevention of gastric cancer by celecoxib in H-pylori-infected mongolian gerbils
    Futagami, Seiji
    Suzuki, Kenji
    Hiratsuka, Tetsuro
    Shindo, Tomotaka
    Hamamoto, Tatsuhiko
    Tatsuguchi, Atsushi
    Ueki, Nobue
    Yoko, Shinji
    Kusunoki, Masafumi
    Wada, Ken
    Miyake, Kazumatsa
    Gudis, Katya
    Tsukui, Taku
    Sakamoto, Choitsu
    GASTROENTEROLOGY, 2006, 130 (04) : A9 - A9
  • [6] Lansoprazole increases serum IgG and IgM in H-pylori-infected patients
    Matsukawa, Y.
    Kurosaka, H.
    Kato, K.
    Hayashi, I.
    Minekawa, K.
    Arakawa, Y.
    Sawada, S.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2007, 20 (01): : 173 - 179
  • [7] Oral immunization against H-pylori in healthy volunteers with low dose E-coli enterotoxin (LT) and recombinant urease.
    Banerjee, S
    Medina-Fatimi, A
    Nichols, R
    Tendler, D
    Michetti, M
    Mach, M
    Simon, J
    Kelly, CP
    Monath, TP
    Michetti, P
    GUT, 2000, 47 : A59 - A59
  • [8] Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate
    Stadtlander, CTKH
    Gangemi, JD
    Khanolkar, SS
    Kitsos, CM
    Farris, HE
    Fulton, LK
    Hill, JE
    Huntington, FK
    Lee, CK
    Monath, TP
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (09) : 1853 - 1862
  • [9] Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection
    Myers, GA
    Ermak, TH
    Georgakopoulos, K
    Tibbitts, T
    Ingrassia, J
    Gray, H
    Kleanthous, H
    Lee, CK
    Monath, TP
    VACCINE, 1999, 17 (11-12) : 1394 - 1403
  • [10] Enhanced levels of human GRO alpha in H-pylori-infected gastric mucosa
    Suzuki, H
    Mori, M
    Suzuki, M
    Miura, S
    Watanabe, K
    Ishii, H
    GASTROENTEROLOGY, 1997, 112 (04) : A301 - A301
12345